Form: S-8

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

November 4, 2024

Documents

EXHIBIT 107

Calculation of Filing Fee Table

FORM S-8
(Form Type)

OPUS GENETICS, INC.
(Exact Name of Registrant as Specified in its Charter)
Newly Registered Securities

 
Security Type
Security
Class
Title
Fee
Calculation
Rule
Amount
Registered
Proposed
Maximum
Offering Price
Per Unit
Maximum
Aggregate
Offering Price
Fee Rate
Amount of
Registration Fee
1
Equity
Common stock, $0.0001 par value
Rule 457(c) and Rule 457(h)
300,000
$1.27
$381,000.00
0.00015310
$58.33
 
Total Offering Amounts:
  
$381,000.00
  
$58.33
           
 
Total Fee Offsets:
      
$58.33
 
Net Fee Due:
      
$58.33

Offering Note
(1)
Opus Genetics, Inc., a Delaware corporation (the “Registrant”), is filing this Registration Statement to register 300,000 shares of common stock, par value $0.0001 per share (the “Common Stock”), for issuance under the Ocuphire Pharma, Inc. 2021 Inducement Plan (the Plan”). Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers such additional and indeterminate number of shares of Common Stock, which may become issuable pursuant to the provisions of the Plan relating to adjustments for changes resulting from a stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration which results in an increase in the number of outstanding shares of Common Stock.
(2)
Estimated in accordance with Rule 457(h) under the Securities Act solely for the purpose of calculating the registration fee, based on the average of the high and low sales prices of the Common Stock reported on the Nasdaq Stock Market on October 28, 2024.